Statistics Publications
Permanent URI for this collection
Browse
Browsing Statistics Publications by Author "Al-Ramahi, Ismael"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis(eLife, 2021) Onur, Tarik Seref; Laitman, Andrew; Zhao, He; Keyho, Ryan; Kim, Hyemin; Wang, Jennifer; Mair, Megan; Wang, Huilan; Li, Lifang; Perez, Alma; de Haro, Maria; Wan, Ying-Wooi; Allen, Genevera; Lu, Boxun; Al-Ramahi, Ismael; Liu, Zhandong; Botas, JuanMost research on neurodegenerative diseases has focused on neurons, yet glia help form and maintain the synapses whose loss is so prominent in these conditions. To investigate the contributions of glia to Huntington's disease (HD), we profiled the gene expression alterations of Drosophila expressing human mutant Huntingtin (mHTT) in either glia or neurons and compared these changes to what is observed in HD human and HD mice striata. A large portion of conserved genes are concordantly dysregulated across the three species; we tested these genes in a high-throughput behavioral assay and found that downregulation of genes involved in synapse assembly mitigated pathogenesis and behavioral deficits. To our surprise, reducing dNRXN3 function in glia was sufficient to improve the phenotype of flies expressing mHTT in neurons, suggesting that mHTT's toxic effects in glia ramify throughout the brain. This supports a model in which dampening synaptic function is protective because it attenuates the excitotoxicity that characterizes HD.Item Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity(Public Library of Science, 2023) Yu, Meigen; Ye, Hui; De-Paula, Ruth B.; Mangleburg, Carl Grant; Wu, Timothy; Lee, Tom V.; Li, Yarong; Duong, Duc; Phillips, Bridget; Cruchaga, Carlos; Allen, Genevera I.; Seyfried, Nicholas T.; Al-Ramahi, Ismael; Botas, Juan; Shulman, Joshua M.Heterozygous variants in the glucocerebrosidase (GBA) gene are common and potent risk factors for Parkinson’s disease (PD). GBA also causes the autosomal recessive lysosomal storage disorder (LSD), Gaucher disease, and emerging evidence from human genetics implicates many other LSD genes in PD susceptibility. We have systemically tested 86 conserved fly homologs of 37 human LSD genes for requirements in the aging adult Drosophila brain and for potential genetic interactions with neurodegeneration caused by α-synuclein (αSyn), which forms Lewy body pathology in PD. Our screen identifies 15 genetic enhancers of αSyn-induced progressive locomotor dysfunction, including knockdown of fly homologs of GBA and other LSD genes with independent support as PD susceptibility factors from human genetics (SCARB2, SMPD1, CTSD, GNPTAB, SLC17A5). For several genes, results from multiple alleles suggest dose-sensitivity and context-dependent pleiotropy in the presence or absence of αSyn. Homologs of two genes causing cholesterol storage disorders, Npc1a / NPC1 and Lip4 / LIPA, were independently confirmed as loss-of-function enhancers of αSyn-induced retinal degeneration. The enzymes encoded by several modifier genes are upregulated in αSyn transgenic flies, based on unbiased proteomics, revealing a possible, albeit ineffective, compensatory response. Overall, our results reinforce the important role of lysosomal genes in brain health and PD pathogenesis, and implicate several metabolic pathways, including cholesterol homeostasis, in αSyn-mediated neurotoxicity.